Article
Plasma-seq: a novel strategy for metastatic prostate cancer analysis
Genome Medicine
Document Type
Article
Disciplines
Publication Version
Published Version
Publication Date
1-1-2013
DOI
10.1186/gm439
Abstract
Personalized genomics will only be useful for monitoring the prognosis of patients with cancer when it becomes much more cost-effective and quicker to apply. A recent study brings this closer to reality with the development of plasma-seq, a rapid, low-cost method that sequences the circulating DNA present in the peripheral blood of patients with cancer. The power of this technique is demonstrated with the examination of tumor genomes from patients with prostate cancer.
Rights
This article is made available under a CC-BY license 4.0. For more information, please visit: https://creativecommons.org/licenses/by/4.0/
Copyright Owner
BioMed Central Ltd
Copyright Date
2013
Language
en
File Format
application/pdf
Citation Information
Caitlin Farris and Jeffrey M Trimarchi. "Plasma-seq: a novel strategy for metastatic prostate cancer analysis" Genome Medicine Vol. 5 (2013) p. 35 Available at: http://works.bepress.com/jeffrey-trimarchi/7/
This article is from Genome Medicine 5 (2013): 35, doi: 10.1186/gm439. Posted with permission.